Featured

AdvaMedDx Priorities 2021

AdvaMed and AdvaMedDx have prioritized supporting MedTech’s mobilization to the pandemic to protect patients and public health through the development of and advocacy on a wide range of policy matters both administrative and legislative to foster innovation, expand access to testing and to bolster testing infrastructure and capability for future pandemic preparedness.

In Vitro Diagnostic COVID-19 Tests

In vitro diagnostic (IVD) manufacturers have taken key steps to increase patient access to coronavirus diagnostic testing in laboratories, hospitals, and other testing sites across the country to guide patient care and protect public health. Learn which companies have developed IVDs that have received Emergency Use Authorization from the U.S. Food and Drug Administration.

Recent Newsletters


See All

Recent Tweets

March 5, 2021 - 11:35am
testing will remain a core component of our nation's fight against the pandemic and we support 's an… https://t.co/mCjZai3UO6
March 3, 2021 - 12:15pm
AdvaMedDx will continue to work closely with , and others to ensure continued supplies of… https://t.co/FrNwBso1Ly
March 2, 2021 - 3:29pm
Our top priority at AdvaMedDx is to maintain the industry's aggressive response to . We are working hard to… https://t.co/XUiGlLEUom